OrderlyMeds logo

OrderlyMeds Review

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.8/10

Best for: budget-conscious shoppers

7.8
★★★3.9/5

OrderlyMeds scores below our bar on medical oversight — read the score breakdown before signing up.

Semaglutide

$74/mo

Tirzepatide

$299/mo
Same price at every dose

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not disclosed

Coaching

Not disclosed

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

Telehealth provider offering one of the lowest 3-month starter prices for compounded GLP-1 medications.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedSemaglutideTirzepatide

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Vetted alternatives to OrderlyMeds

6.4/ 10
Verified partner

Direct Meds

Best for: listed for disclosure only — see its FDA warning and BBB complaints first

★★★☆☆3.2/5

Editorial score · methodology

$249/mosemaglutide
$299/motirzepatide
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript VerifiedFDA Warning
Get StartedRead full Direct Meds review →
7.6/ 10
Verified partner

Maximus

Best for: men seeking compounded GLP-1 alongside testosterone optimization

★★★3.8/5

Editorial score · methodology

$250/mosemaglutide
$360/motirzepatide
CompoundedSemaglutideTirzepatideOrforglipronSermorelinFDA Warning
Get StartedRead full Maximus review →
8.0/ 10
Verified partner

Sesame Care

Best for: Brand-name GLP-1s at cash prices, no compounding

★★★★4/5

Editorial score · methodology

$149/mosemaglutide
$299/motirzepatide
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Sesame Care review →
OrderlyMeds logo
3.9 / 5
Our editorial rating
Visit OrderlyMeds

from $74/mo · no insurance needed

OrderlyMeds at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$74/mo
Pricing model
Flat — dose increases don't raise the monthly price
What's included
Medication · Consult · Shipping
FDA status
1 FDA warning letter on record — see below

How we scored OrderlyMeds

Each dimension is scored algorithmically from OrderlyMeds’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.

Value25%

9.7/10

At $74/mo, OrderlyMeds runs about 56% below the $169 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.

Effectiveness25%

8.5/10

OrderlyMeds offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

7.5/10

Online intake and platform experience — consult included in the price; 3 platform features disclosed.

Trust & Safety15%

5.7/10

Core details confirmed by our editors; an FDA warning letter is on file (see flag above) (last checked 2026-08-02).

Accessibility10%

6.5/10

OrderlyMeds's exact state footprint isn't published — confirm coverage in your state before signing up.

Support10%

6.3/10

OrderlyMeds provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
585providers compared
100%verified against live provider sites
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this OrderlyMeds review

Last checked August 2026
  • Confirmed current pricing across 3 dose/plan tiers
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.

What to expect when you sign up with OrderlyMeds

We walked OrderlyMeds’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Check eligibility in under two minutes.
  2. 2Share medical history and weight goals via a secure online form.
  3. 3A licensed physician reviews your information, with a video chat if required by your state.
  4. 4Receive a personalized treatment plan and prescription if approved.
  5. 5Medication is compounded and shipped to your home in discreet packaging.
Price shown before you start
  • Pricing shown up front: compounded GLP-1 from $74/mo intro ($149/mo after); GLP-1/GIP from $149/mo intro ($299/mo after).
  • Brand-name options also priced: Zepbound $1,498/mo, Wegovy $1,839/mo.
  • Video consultation only if required by the patient's state; no explicit lab requirement.
  • Medication compounded at U.S.-based licensed pharmacies; delivery timeframe not specified.
  • No refund/cancellation policy disclosed on the homepage.

OrderlyMeds customer support

GLP-1 medications OrderlyMeds offers

Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.

Pricing

Prices re-verified

3-month starter promoCompounded
$74/mo
semaglutide
Ongoing after starter periodCompounded
$149/mo
semaglutide
Ongoing (tirzepatide)Compounded
$299/mo
tirzepatide

Ready to get started?

Plans and promotions change often — check OrderlyMeds's current pricing and active discounts before you decide.

See OrderlyMeds pricing →

What we like

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Watch-outs

  • Limited public information on program details

OrderlyMeds: the rock-bottom starter price, and the trade-offs behind it

OrderlyMeds is built around a single, blunt selling point: one of the lowest entry prices for compounded GLP-1 medication you will find anywhere. Its SimpleStart program puts your first stretch of treatment at just $74 a month, with the doctor's visit, the medication, your syringes, and shipping all rolled into that number. If your main question is 'what is the cheapest way to actually start semaglutide or tirzepatide,' OrderlyMeds answers it directly. The catch is that it asks you to trust a program that publishes very little about how it operates. For budget-conscious shoppers willing to do some homework before signing up, it can be worth a hard look. For anyone who wants transparency about the pharmacy and oversight behind their meds, it will feel thin.

How the pricing actually works: flat per dose, then a step up

The headline rate is a starter offer, not your forever price, and it helps to understand the shape of it before you commit. The SimpleStart deal covers your first three months for $74 a month, billed as a single upfront payment for the quarter rather than month to month. After that starter window, semaglutide moves to a standard ongoing monthly rate, and tirzepatide sits at a higher ongoing rate of its own. None of those step-up numbers are hidden, but they are easy to miss when the marketing leads with the teaser figure, so budget for the real ongoing cost, not just the first quarter.

The genuinely useful wrinkle in OrderlyMeds' model is that pricing is flat across doses. The company is explicit about it: the price does not climb as your dose climbs. As one line on its site puts it, 'Does the price increase with the dose? No! All of our medication is available for the same price per dosage.' That matters because most people titrate upward over the first several months, and at many competitors your monthly bill creeps up alongside your dose. Here, the number you sign up at is the number you keep paying, which makes long-term budgeting genuinely predictable.

What is included in the price

OrderlyMeds bundles the things that are easy to forget when you compare GLP-1 programs on the sticker price alone. Per the company, your monthly fee covers:

  • The telehealth doctor's visit and prescription, with no separate consult fee bolted on
  • The compounded medication itself
  • Syringes for self-injection
  • Shipping to your door

That all-in structure is part of why the entry price reads as low as it does. Some rivals advertise a slim medication price and then add a membership or consultation charge on top; OrderlyMeds folds those into one figure. When you stack it against the roughly $169 category median, the value case is real, at least for the starter period.

The medications, and how they are dispensed

OrderlyMeds offers compounded semaglutide and compounded tirzepatide, the same two molecules behind the big brand-name GLP-1 drugs, prepared by a compounding pharmacy rather than the original manufacturer. There is no brand-name Wegovy, Ozempic, or Zepbound option here; this is a compounded-only program, which is exactly how it reaches these prices. Compounded medication is legal to prescribe through licensed pharmacies, but it is not FDA-reviewed the way a brand product is, so the quality of the specific pharmacy doing the work matters a great deal.

Where the transparency runs out

This is the part to read slowly. OrderlyMeds does not publicly name its compounding pharmacy, and we have no accreditation detail on file for whoever fills its prescriptions. For a compounded-medication program, that is the single most important fact a buyer would want, and its absence is the clearest mark against this provider. We also could not confirm which states OrderlyMeds serves; it does not disclose its coverage map, so you will need to verify availability for your own state during signup rather than assuming it operates where you live. OrderlyMeds has an FDA warning letter on file, which we set out in the regulatory notice below. But 'no red flag' is not the same as 'verified oversight,' and the documentation simply is not there to fully vet who is behind the medicine.

Who should choose OrderlyMeds, and who should skip it

Choose it if price is your deciding factor, you are comfortable with compounded GLP-1s, and you are willing to confirm the program details yourself before paying. The flat-per-dose model and all-inclusive starter price make it one of the cheapest credible on-ramps to treatment, especially for that first quarter.

Skip it if you want brand-name medication, if you need to know exactly which accredited pharmacy is compounding your dose, or if you would rather pay more for a provider that publishes its state coverage, support model, and refund terms up front. Patients who value documentation and hand-holding over the lowest number will be happier elsewhere.

Bottom line

OrderlyMeds is a price-first GLP-1 provider that delivers exactly what it advertises: an unusually cheap, all-inclusive, flat-rate starter program for compounded semaglutide and tirzepatide. The flat-dose pricing is a real, underrated advantage for anyone planning to titrate up. What holds it back is information, not price: an undisclosed pharmacy, no published accreditation, and an unclear state map mean you are trusting more and verifying less than you should have to. If you go in with eyes open, confirm coverage in your state, and treat the $74 figure as a starter rate rather than your permanent bill, it earns its place on a budget shortlist. See our scoring methodology for how we weigh price against transparency.

Shopping around? RxPepsDirect ($64/month) and Sunlight ($88/month) are the nearest alternatives to OrderlyMeds in our rankings.

The Bottom Line

OrderlyMeds scores below our bar on medical oversight — read the score breakdown before signing up.

Score: 7.8/10Best for: budget-conscious shoppersFrom: $74/mo

Ready to start with OrderlyMeds?

Starting at $74/month. See current pricing and start your free consultation.

OrderlyMeds might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
  • If you want built-in coaching and behavior-change support, consider Found.

Frequently Asked Questions

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Regulatory notice

OrderlyMeds received an FDA warning letter dated June 8, 2026

The letter concerns false & misleading claims/misbranded (telehealth). FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity — companies often respond with corrective action.

Read the full letter →

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this OrderlyMeds review:

Sources & methodology — as of August 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board StandardsAccreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)New England Journal of Medicine.PMID: 40334173.

See OrderlyMeds's current pricing

Plans start at $74/month. Start your free consultation to check eligibility and today's price.